SUTRO BIOPHARMA, INC.
STRO—
$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-22.49
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$102.48M
Net income
$-191.09M
Net margin
-186.5%
Gross margin
—
Dividends & financials
SUTRO BIOPHARMA, INC. (STRO) reported revenue of $102.48M and net income of $-191.09M, or $-22.49 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
